In our study, we also found that levels of Mfn-2 increased in preeclampsia patients parallel to increased anti-angiogenic factors such as sFlt-1 and sEng, indicating increased endothelial dysfunction due to hypoxia. The gene discussed is MFN2; the disease is preeclampsia.